채용
岗位职责:
- 负责结合活性、细胞生物学活性、蛋白含量、HCP残留、Protein A残留、DNA残留检测,及数据分析等;
- 参与或主导生化分析方法的优化、转移、验证工作,包括撰写方案和报告,方案执行,及数据分析;
- 负责管理和维护生化组及QC相关文件,包括撰写、复核、变更方法程序等;
- 每项工作应遵守数据可靠性原则,符合ALCOA+ (可追溯、清晰、同步、原始、准确、完整、一致、持久、可用)规定;
- 支持生化分析仪器的安装调试、验证等工作,负责仪器的日常维护保养;
- 有责任和义务第一时间汇报异常(偏差、OOS、OOT、OOE、AE),并按相关规定参与调查处理;不断学习和提升,加强异常问题处理的锻炼;
- 负责生化实验室试剂耗材、标准品等管理,现场5S维护;严格遵守公司EHS要求,确保操作安全;
- 负责跟踪和掌握国内外关于生化方法相关的法规和指南要求,并进行差异分析,制定升级措施;
- 其它公司和领导安排的工作。
任职要求:
- 至少3年及以上抗体药物的生化分析经验;
- 掌握至少3种实验原理及方法:结合活性、细胞生物学活性、蛋白含量、HCP残留、Protein A残留,及DNA残留;
- 了解现行版《中国药典》和GMP等相关法律法规,熟悉ICH Q2;
- 能在GMP环境中独立执行分析工作,并最大限度地减少实验室误差;能指导生化工程师工作;
- 英语看说写熟练;
- 具备良好的职业素养和团队协助能力;
- 熟练使用 MS-Word, MS-Excel, MS-Outlook等办公软件。
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고
BioNTech 소개

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
직원 수
Mainz that develops immunotherapies
본사 위치
$21.7B
기업 가치
리뷰
4.0
10개 리뷰
워라밸
2.5
보상
3.8
문화
4.2
커리어
3.5
경영진
3.2
75%
친구에게 추천
장점
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
단점
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
연봉 정보
70개 데이터
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0개 리포트
$53,767
총 연봉
기본급
$21,507
주식
$26,884
보너스
$5,377
$37,637
$69,897
면접 경험
1개 면접
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
뉴스 & 버즈
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
2d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
4d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
1w ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
1w ago




